Blood pressure and heart rate variability are linked with hyperphosphatemia in chronic kidney disease patients

References

• Bilo G, Parati G. 2018. Blood pressure variability and kidney disease: Another vicious circle? J Hypertens. 36(5):1019–21. doi:10.1097/HJH.0000000000001707. PMID:29578957.
   PubMed Web of Science ®Google Scholar
• Carr O, De Vos M, Saunders KEA. 2018. Heart rate variability in bipolar disorder and borderline personality disorder: A clinical review. Evid Based Ment Health. 21(1):23–30. doi:10.1136/eb-2017-102760. PMID:29223951.
   PubMed Web of Science ®Google Scholar
• Chen SC, Huang JC, Tsai YC, Hsiu-Chin Mai RN, Jui-Hsin Chen RN, Kuo PL, Chang JM, Hwang SJ, Chen HC. 2016. Heart rate variability change before and after hemodialysis is associated with overall and cardiovascular mortality in hemodialysis. Sci Rep. 6:20597. doi:10.1038/srep20597. PMID:26854202.
   PubMed Web of Science ®Google Scholar
• Drawz PE, Abdalla M, Rahman M. 2012. Blood pressure measurement: Clinic, home, ambulatory, and beyond. Am J Kidney Dis. 60(3):449–62. doi:10.1053/j.ajkd.2012.01.026. PMID:22521624.
   PubMed Web of Science ®Google Scholar
• Enevoldsen LH, Heaf J, Hojgaard L, Zerahn B, Hasbak P. 2017. Increased technetium-99 m hydroxy diphosphonate soft tissue uptake on bone scintigraphy in chronic kidney disease patients with secondary hyperparathyroidism: Correlation with hyperphosphataemia. Clin Physiol Funct Imaging. 37(2):131–36. doi:10.1111/cpf.12276. PMID:26148143.
   PubMed Web of Science ®Google Scholar
• Fava C, Burri P, Almgren P, Arcaro G, Groop L, Lennart Hulthen U, Melander O. 2005. Dipping and variability of blood pressure and heart rate at night are heritable traits. Am J Hypertens. 18(11):1402–07. doi:10.1016/j.amjhyper.2005.05.011. PMID:16280271.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Ayala DE, Portaluppi F. 2015. Ambulatory blood pressure monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults. Chronobiol Int. 32(10):1329–42. doi:10.3109/07420528.2015.1113804. PMID:26587588.
   PubMed Web of Science ®Google Scholar
• Hoshide S, Cheng HM, Huang Q, Park S, Park CG, Chen CH, Wang JG, Kario K, Characteristics On the ManagEment of Hypertension in Asia – Morning Hypertension Discussion G. 2017. Role of ambulatory blood pressure monitoring for the management of hypertension in Asian populations. J Clin Hypertens (Greenwich). 19(12):1240–45. doi:10.1111/jch.13086. PMID:28834205.
   PubMed Web of Science ®Google Scholar
• Huang JC, Kuo IC, Tsai YC, Lee JJ, Lim LM, Chen SC, Chiu YW, Chang JM, Chen HH. 2017. Heart rate variability predicts major adverse cardiovascular events and hospitalization in maintenance hemodialysis patients. Kidney Blood Press Res. 42(1):76–88. doi:10.1159/000469716. PMID:28315879.
   PubMed Web of Science ®Google Scholar
• Isakova T, Nickolas TL, Denburg M, Yarlagadda S, Weiner DE, Gutierrez OM, Bansal V, Rosas SE, Nigwekar S, Yee J, et al. 2017. KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 70(6):737–51. doi:10.1053/j.ajkd.2017.07.019. PMID:28941764.
   PubMed Web of Science ®Google Scholar
• Isakova T, Xie H, Barchi-Chung A, Smith K, Sowden N, Epstein M, Collerone G, Keating L, Juppner H, Wolf M. 2012. Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol. Clin J Am Soc Nephrol. 7(5):820–28. doi:10.2215/CJN.11721111. PMID:22383746.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Shen Z, Zhang J, Xing C, Zha X, Shen C, Zeng M, Yang G, Mao H, Zhang B, et al. 2016. Parathyroidectomy increases heart rate variability and leptin levels in patients with stage 5 chronic kidney disease. Am J Nephrol. 44(3):245–54. doi:10.1159/000449018. PMID:27598394.
   PubMed Web of Science ®Google Scholar
• Jubiz W, Canterbury JM, Reiss E, Tyler FH. 1972. Circadian rhythm in serum parathyroid hormone concentration in human subjects: Correlation with serum calcium, phosphate, albumin, and growth hormone levels. J Clin Invest. 51(8):2040–46. doi:10.1172/JCI107010. PMID:5054463.
   PubMed Web of Science ®Google Scholar
• Kanbay M, Isik B, Akcay A, Ozkara A, Karakurt F, Turgut F, Alkan R, Uz E, Bavbek N, Yigitoglu R, et al. 2007. Relation between serum calcium, phosphate, parathyroid hormone and ‘nondipper’ circadian blood pressure variability profile in patients with normal renal function. Am J Nephrol. 27(5):516–21. doi:10.1159/000107489. PMID:17703091.
   PubMed Web of Science ®Google Scholar
• Kario K, Shimada K. 2004. Risers and extreme-dippers of nocturnal blood pressure in hypertension: Antihypertensive strategy for nocturnal blood pressure. Clin Exp Hypertens. 26(2):177–89. PMID:15038628.
   PubMed Web of Science ®Google Scholar
• Kemp GJ, Blumsohn A, Morris BW. 1992. Circadian changes in plasma phosphate concentration, urinary phosphate excretion, and cellular phosphate shifts. Clin Chem. 38(3):400–02. PMID: 1547558.
   PubMed Web of Science ®Google Scholar
• Lim CT, Yap XH, Chung KJ, Khalid MA, Yayha N, Latiff LA, Goh BL. 2015. Predictor of cardiovascular risks in end stage renal failure patients on maintenance dialysis. Pak J Med Sci. 31(6):1300–05. doi:10.12669/pjms.316.8039. PMID:26870086.
   PubMed Web of Science ®Google Scholar
• Mena LJ, Felix VG, Melgarejo JD, Maestre GE. 2017. 24-hour blood pressure variability assessed by average real variability: A systematic review and meta-analysis. J Am Heart Assoc. 6:10. doi:10.1161/JAHA.117.006895. PMID:29051214.
   Web of Science ®Google Scholar
• Nakai K, Fujii H, Watanabe K, Watanabe S, Awata R, Kono K, Yonekura Y, Goto S, Nishi S. 2016. Riser pattern is a predictor of kidney mortality among patients with chronic kidney disease. Clin Exp Hypertens. 38(5):476–81. doi:10.3109/10641963.2016.1163368. PMID:27367452.
   PubMed Web of Science ®Google Scholar
• O’Brien E. 2007. Is the case for ABPM as a routine investigation in clinical practice not overwhelming? Hypertension. 50(2):284–86. doi:10.1161/HYPERTENSIONAHA.107.092783. PMID:17562978.
   PubMed Web of Science ®Google Scholar
• Oh YK, Chin HJ. 2017. Discrepancies in clinic and ambulatory blood pressure in Korean chronic kidney disease patients. J Korean Med Sci. 32(5):772–81. doi:10.3346/jkms.2017.32.5.772. PMID:28378550.
   PubMed Web of Science ®Google Scholar
• Ohashi N, Isobe S, Ishigaki S, Yasuda H. 2017. Circadian rhythm of blood pressure and the renin-angiotensin system in the kidney. Hypertens Res. 40(5):413–22. doi:10.1038/hr.2016.166. PMID:27904154.
   PubMed Web of Science ®Google Scholar
• Parati G, Ochoa JE, Lombardi CBilo G. 2013. Assessment and management of blood-pressure variability. Nat Rev Cardiol. 10(3):143-155.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. 2012. Circadian rhythms and cardiovascular health. Sleep Med Rev. 16(2):151–66. doi:10.1016/j.smrv.2011.04.003. PMID:21641838.
   PubMed Web of Science ®Google Scholar
• Poulikakos D, Malik M, Banerjee D. 2014. Parathyroid hormone and heart rate variability in haemodialysis patients. Nephron Clin Pract. 126(3):110–15. doi:10.1159/000360542. PMID:24686193.
   PubMedGoogle Scholar
• Ranpuria R, Hall M, Chan CT, Unruh M. 2008. Heart rate variability (HRV) in kidney failure: Measurement and consequences of reduced HRV. Nephrol Dial Transplant. 23(2):444–49. doi:10.1093/ndt/gfm634. PMID:18003665.
   PubMed Web of Science ®Google Scholar
• Salles GF, Ribeiro FM, Guimaraes GM, Muxfeldt ESCardoso CR. 2014. A reduced heart rate variability is independently associated with a blunted nocturnal blood pressure fall in patients with resistant hypertension. J Hypertens. 32(3):644-651.
   PubMed Web of Science ®Google Scholar
• Sarafidis PA, Ruilope LM, Loutradis C, Gorostidi M, De La Sierra A, De La Cruz JJ, Vinyoles E, Divison-Garrote JA, Segura J, Banegas JR. 2018. Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients. J Hypertens. 36(5):1076–85. doi:10.1097/hjh.0000000000001670. PMID:29465710.
   PubMed Web of Science ®Google Scholar
• Saran R, Robinson B, Abbott KC, Agodoa LYC, Bhave N, Bragg-Gresham J, Balkrishnan R, Dietrich X, Eckard A, Eggers PW, et al. 2018. US renal data system 2017 annual data report: Epidemiology of kidney disease in the United States. Am J Kidney Dis. 71(3s1):A7. doi:10.1053/j.ajkd.2018.01.002. PMID:29477157.
   PubMedGoogle Scholar
• Sessa F, Anna V, Messina G, Cibelli G, Monda V, Marsala G, Ruberto M, Biondi A, Cascio O, Bertozzi G, et al. 2018. Heart rate variability as predictive factor for sudden cardiac death. Aging (Albany NY). 10(2):166–77. doi:10.18632/aging.101386. PMID:29476045.
   PubMedGoogle Scholar
• Shaman AM, Kowalski SR. 2016. Hyperphosphatemia management in patients with chronic kidney disease. Saudi Pharm J. 24(4):494–505.
   PubMed Web of Science ®Google Scholar
• Sigurdsson MI, Waldron NH, Bortsov AV, Smith SB, Maixner W. 2018. Genomics of cardiovascular measures of autonomic tone. J Cardiovasc Pharmacol. 71:180–91. doi:10.1097/fjc.0000000000000559. PMID:29300220.
   PubMed Web of Science ®Google Scholar
• Solbu MD, Thomson PC, Macpherson S, Findlay MD, Stevens KK, Patel RK, Padmanabhan S, Jardine AG, Mark PB. 2015. Serum phosphate and social deprivation independently predict all-cause mortality in chronic kidney disease. BMC Nephrol. 16:194. doi:10.1186/s12882-015-0187-1. PMID:26627078.
   PubMed Web of Science ®Google Scholar
• Sun YP, Yang WJ, Li SH, Han YY, Liu J. 2017. Clinical epidemiology of mineral bone disorder markers in prevalent hemodialysis patients in the Xinjiang Uyghur autonomous region in China. Biomed Res Int. 2017:2516934. doi:10.1155/2017/2516934. PMID:28299319.
   PubMed Web of Science ®Google Scholar
• Takeda N, Maemura K. 2016. Circadian clock and the onset of cardiovascular events. Hypertens Res. 39(6):383–90. doi:10.1038/hr.2016.9. PMID:26888119.
   PubMed Web of Science ®Google Scholar
• Tisler A, Logan AG, Akocsi K, Tornoci L, Kiss I. 2008. Circadian variation of death in hemodialysis patients. Am J Kidney Dis. 51(1):53–61. doi:10.1053/j.ajkd.2007.09.019. PMID:18155533.
   PubMed Web of Science ®Google Scholar
• Trivedi H, Szabo A, Zhao S, Cantor T, Raff H. 2015. Circadian variation of mineral and bone parameters in end-stage renal disease. J Nephrol. 28(3):351–59. doi:10.1007/s40620-014-0124-6. PMID:25138650.
   PubMed Web of Science ®Google Scholar
• Vervloet MG, Sezer S, Massy ZA, Johansson L, Cozzolino M, Fouque D. 2017. The role of phosphate in kidney disease. Clin Exp Nephrol. 13(1):27–38. doi:10.1038/nrneph.2016.164. PMID:27867189.
   Google Scholar
• Wang C, Ye Z, Li Y, Zhang J, Zhang Q, Ma X, Peng H, Lou T. 2016. Prognostic value of reverse dipper blood pressure pattern in chronic kidney disease patients not undergoing dialysis: Prospective cohort study. Sci Rep. 6:34932. doi:10.1038/srep34932. PMID:27713498.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang J, Liu X, Li C, Ye Z, Peng H, Chen Z, Lou T. 2013a. Reversed dipper blood-pressure pattern is closely related to severe renal and cardiovascular damage in patients with chronic kidney disease. PLoS One. 8(2):e55419. doi:10.1371/journal.pone.0055419. PMID:23393577.
   PubMed Web of Science ®Google Scholar
• Wang N, Wang X, Sun B, Zeng M, Xing C, Zhao X, Yang J. 2013b. Role of TGF-beta1 in production of fibronectin in vascular smooth muscle cells cultured under high-phosphate conditions. J Nephrol. 26(1):213–18. doi:10.5301/jn.5000127. PMID:22641576.
   PubMed Web of Science ®Google Scholar
• Wang N, Wang X, Xing C, Sun B, Yu X, Hu J, Liu J, Zeng M, Xiong M, Zhou S, et al. 2010. Role of TGF-beta1 in bone matrix production in vascular smooth muscle cells induced by a high-phosphate environment. Nephron Exp Nephrol. 115(3):e60–68. doi:10.1159/000313831. PMID:20424484.
   PubMedGoogle Scholar
• Yang G, Zhang B, Zha XM, Wang NN, Xing CY. 2014. Total parathyroidectomy with autotransplantation for a rare disease derived from uremic secondary hyperparathyroidism, the uremic leontiasis ossea. Osteoporos Int. 25(3):1115–21. doi:10.1007/s00198-013-2488-1. PMID:23989901.
   PubMed Web of Science ®Google Scholar
• Yaniv Y, Lakatta EG. 2015. The end effector of circadian heart rate variation: The sinoatrial node pacemaker cell. BMB Reports. 48(12):677–84. doi:10.5483/BMBRep.2015.48.12.061. PMID:25999176.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang N. 2014. Prognostic significance and therapeutic option of heart rate variability in chronic kidney disease. Int Urol Nephrol. 46(1):19–25. doi:10.1007/s11255-013-0421-3. PMID:23539130.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yu X, Sun B, Bai J, Wei Y, Zha X, Cui Y, Zeng M, Zhang J, Liu J, et al. 2013. Parathyroidectomy and heart rate variability in patients with stage 5 CKD. Clin J Am Soc Nephrol. 8(8):1378–87. doi:10.2215/cjn.10381012. PMID:23660181.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yang S, Chen J, Ma J, Ren Y. 2017. Associations of parathyroid hormone levels and mineral parameters with heart rate variability in patients with end-stage renal disease. Int Urol Nephrol. 49(6):1079–85. doi:10.1007/s11255-017-1513-2. PMID:28243964.
   PubMed Web of Science ®Google Scholar
• Zhang LN, Yang G, Cheng C, Shen C, Cui YY, Zhang J, Zhang JJ, Shen ZX, Zeng M, Ge YF, et al. 2015. Plasma FGF23 levels and heart rate variability in patients with stage 5 CKD. Osteoporos Int. 26(1):395–405. doi:10.1007/s00198-014-2862-7. PMID:25224292.
   PubMed Web of Science ®Google Scholar